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The nucleosome remodeling and deacetylase (NuRD) complex plays an important role in
gene expression regulation, stem cell self-renewal, and lineage commitment. However, little
is known about the dynamics of NuRD during cellular differentiation. Here, we study these
dynamics using genome-wide proﬁling and quantitative interaction proteomics in mouse
embryonic stem cells (ESCs) and neural progenitor cells (NPCs). We ﬁnd that the genomic
targets of NuRD are highly dynamic during differentiation, with most binding occurring at
cell-type speciﬁc promoters and enhancers. We identify ZFP296 as an ESC-speciﬁc NuRD
interactor that also interacts with the SIN3A complex. ChIP-sequencing in Zfp296 knockout
(KO) ESCs reveals decreased NuRD binding both genome-wide and at ZFP296 binding sites,
although this has little effect on the transcriptome. Nevertheless, Zfp296 KO ESCs exhibit
delayed induction of lineage-speciﬁc markers upon differentiation to embryoid bodies. In
summary, we identify an ESC-speciﬁc NuRD-interacting protein which regulates genome-
wide NuRD binding and cellular differentiation.
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The nucleosome remodeling and deacetylase (NuRD) com-plex is an evolutionarily conserved chromatin-associatedprotein complex which regulates gene expression and also
plays a role in the DNA damage response1–3. The complex
contains two enzymatic functions: histone deacetylase activity,
catalyzed by HDAC1 and HDAC2, and ATP-dependent chro-
matin remodeling activity, catalyzed by CHD3, CHD4, or CHD5.
Other core subunits of the complex include DOC-1 (also known
as CDK2AP1), GATAD2A and -B, RBBP4 and -7, MTA1, -2, and
-3, and MBD2 and -3. Some of these paralogous subunits deﬁne
mutually exclusive NuRD subcomplexes with distinct biological
functions4,5. In addition, NuRD has been shown to interact with a
large number of proteins such as FOG1, SALL4, JUN, and Ikaros,
some of which serve to recruit NuRD to speciﬁc target sites in the
genome6–9.
Due to the presence of the HDAC1/2 subunits, NuRD can be
categorised as part of the HDAC1/2 complex family, other
members of which are the SIN3 and CoREST complexes10.
Although HDAC1/2 complexes have traditionally been classiﬁed
as transcriptional co-repressor complexes, recent genome-wide
analyses revealed that NuRD is mainly associated with promoters
and enhancers of genes that are actively being transcribed. The
exact role of NuRD in regulating gene expression is still not
completely understood, but one hypothesis is that NuRD mainly
serves to ﬁne-tune expression levels of target genes rather than
enabling stable gene repression11–13.
Apart from its functions in gene expression and the DNA
damage response, the NuRD complex also regulates cell fate and
lineage commitment during early development, and has been
reported to be part of the embryonic stem cell pluripotency
network14–16. As such, numerous studies have investigated the
composition and genome-wide proﬁle of the NuRD complex in
embryonic stem cells (ESCs). Yet less is known about the
dynamics of the NuRD complex, both at the genomic and pro-
teomic level, during ESC differentiation.
Here, we perform an integrative proteomic and genomic
characterization of the MBD3/NuRD complex in undifferentiated
mouse ESCs as well as neural progenitor cells (NPCs), which we
obtain through in vitro differentiation of ESCs17. Our data reveal
that the genome-wide binding of MBD3/NuRD is highly dynamic
during differentiation, with most ESC-speciﬁc binding occurring
at promoters and enhancers. MBD3/NuRD afﬁnity puriﬁcations
followed by mass spectrometry in ESCs and NPCs identify zinc
ﬁnger protein 296 (ZFP296) as a prominent, stem cell-speciﬁc
NuRD interactor. Reciprocal ZFP296 puriﬁcations conﬁrm this
interaction and reveal that ZFP296 is a shared interactor of the
NuRD and SIN3A complexes in ESCs. Knockout (KO) of Zfp296
in ESCs leads to a decrease in NuRD binding, both genome-wide
as well as at ZFP296 target genes. Additionally, the expression of
several lineage commitment genes is perturbed in the absence of
ZFP296 in ESCs, and we observe that Zfp296 KO ESCs display
delayed differentiation upon withdrawal of leukaemia inhibitory
factor (LIF). In summary, we identify ZFP296 as a stem cell-
speciﬁc NuRD-interacting protein which regulates genome-wide
NuRD localization and differentiation of ESCs.
Results
NuRD binding is highly dynamic during differentiation. To
investigate the genome-wide DNA binding dynamics of the
NuRD complex during mouse ESC differentiation, we performed
chromatin immunoprecipitation followed by deep sequencing
(ChIP-seq) using antibodies against two endogenous NuRD
subunits, MBD3 and CHD4, in both ESCs and NPCs. In ESCs,
1585 binding sites for MBD3 were identiﬁed in two biological
replicates; the large majority of MBD3 sites (1354) also
co-localized with CHD4 peaks, indicating that these are genuine
NuRD binding sites (Fig. 1a). ChIP-seq analysis of CHD4 iden-
tiﬁed a large number of peaks (7262) that did not overlap with
MBD3, which is in agreement with recent data and suggests that
these could be sites where CHD4 acts independently of
NuRD13,18. A similar distribution of MBD3 and CHD4 sites was
obtained in NPCs (Fig. 1a). Comparing binding sites in ESCs and
NPCs revealed a surprisingly limited overlap, suggesting that
many NuRD binding sites (>95%) are cell-type speciﬁc (Fig. 1a–c;
Supplementary Fig. 1a). NuRD binding sites that are shared
between the two cell types are enriched for transcription start
sites (TSS) and are marked with H3K4me3 and H3K27ac in both
ESCs and NPCs, suggesting that these occur at the promoters of
constitutively active genes (Fig. 1d, e). Interestingly, the H3K27ac
signal here shows a single peak rather than a double peak, which
is in agreement with recent data on H3K27ac levels at NuRD-
bound loci, where a single or double H3K27ac peak is char-
acteristic of promoters or active enhancers, respectively13. In
contrast, cell-type speciﬁc NuRD binding sites mostly (72% for
NPC and 82% for ESC) map to intergenic and intronic regions
(Fig. 1d). ESC-speciﬁc NuRD sites are marked with H3K27ac,
H3K4me1, H3K4me3, and p30019, indicating that dynamic
NuRD binding likely occurs at active promoters and enhan-
cers19,20 (Fig. 1e). Remarkably, NPC-speciﬁc NuRD sites are not
marked with any of the histone marks that we examined, but do
seem to be highly methylated in both cell types (Fig. 1e; Sup-
plementary Fig. 1b). The SOX2 and POU5F1/OCT4 DNA
binding motifs are enriched under ESC-speciﬁc NuRD binding
sites (Supplementary Fig. 1c) and genes nearby ESC-enriched
peaks are involved in regulating development (Supplementary
Fig. 1d, Supplementary Data 1). These ﬁndings support previous
studies that revealed a role for NuRD in regulation of the plur-
ipotency network14–16. NPC-speciﬁc NuRD binding sites are
strongly enriched for the FOS/JUN DNA binding motif (Sup-
plementary Fig. 1c). This observation is in agreement with a
recent study, which showed that the transactivation domain of c-
JUN can recruit the NuRD complex to AP-1 target genes8.
Consistent with our ﬁndings that shared NuRD binding sites
occur at the TSSs of constitutively active genes, we found that
genes nearby shared NuRD peaks were enriched for GO terms
related to housekeeping functions (Supplementary Fig. 1d). In
summary, these experiments revealed that NuRD binding is
highly dynamic during cellular differentiation and that these
dynamic NuRD sites map to promoters and putative enhancers in
ESCs.
ZFP296 is an ESC-speciﬁc NuRD interactor. Next, we set out
to identify cell-type speciﬁc NuRD subunits or interactors,
which could potentially affect NuRD binding to target genes in a
cell-type speciﬁc manner, thereby explaining the observed
dynamic binding. To this end, we created an MBD3-GFP
expressing ESC line using bacterial artiﬁcial chromosome
(BAC) TransGeneOmics21, and also differentiated this line
in vitro to NPCs. Importantly, expression levels of the MBD3-
GFP transgene in these cell lines are similar to or lower than the
expression level of the endogenous MBD3 protein (Supplemen-
tary Fig. 2a, Supplementary Fig. 4). Nuclear extracts from MBD3-
GFP expressing ESCs and NPCs were subjected to GFP afﬁnity
enrichment in triplicate using GFP nanobodies. Afﬁnity enriched
proteins were then on-bead digested and analysed by nLC-MS/
MS. As shown in Fig. 2a, b and Supplementary Fig. 2b, we
identiﬁed a large number of overlapping MBD3-interacting pro-
teins in ESCs and NPCs. We then calculated the intensity-based
absolute quantiﬁcation (iBAQ) values of the most predominant
and statistically signiﬁcant MBD3-interacting proteins in both
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cell types, which can be used to estimate the relative abundance
(stoichiometry) in afﬁnity puriﬁcations22 (Supplementary
Data 2). This analysis revealed several ESC-enriched MBD3
interactors (Fig. 2c; Supplementary Fig. 2c) including the SALL
family of proteins, which have been described previously as stem
cell-speciﬁc NuRD interactors23,24. The SALL proteins are in fact
core components of the NuRD complex in ESCs (Fig. 2c; Sup-
plementary Fig. 2c, d, Supplementary Fig. 4) as their relative
abundance is nearly 1:1 with MBD3. The most ESC-enriched
MBD3 interactor is ZFP296 (Fig. 2c; Supplementary Fig. 2b, c), a
relatively uncharacterized protein that carries six putative DNA
binding zinc ﬁngers and has been proposed to act as a tran-
scription factor25. Interestingly, ZFP296 is a known marker
protein for pluripotency and has been shown to stimulate iPSC
reprogramming driven by OCT4, SOX2, KLF4 and c-MYC
(OSKM)25. Puriﬁcation of MBD3-GFP from the nuclear pellet
fraction obtained after nuclear extraction revealed that the SALL4
and ZFP296 interaction with NuRD was reduced in tightly
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Fig. 1 Dynamic NuRD binding sites map to active promoters and enhancers in ESCs. a Venn diagrams summarizing NuRD ChIP-seq results in embryonic
stem cells (ESC) and neural progenitor cells (NPC). b UCSC genome browser screenshots of example loci where NuRD binding is shared between ESC and
NPC (left), enriched in ESC (middle), or enriched in NPC (right). c Heat map showing the ChIP-seq read density for MBD3 and CHD4 in ESC and NPC,
centred on the union of MBD3 peaks from ESC and NPC. d Genomic distribution of NuRD ChIP-seq peaks from each class as shown in b and c. TSS peaks
were +5 kb/−1 kb from a transcription start site. e Band plots of four different histone marks and p300 (in ESCs, publicly available data19) ChIP-seq at
MBD3 binding sites for each class of NuRD binding. See also Supplementary Fig. 1
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chromatin-bound NuRD compared to lightly chromatin-bound
or unbound NuRD (Supplementary Fig. 2e, f). The iBAQ value of
ZFP296 relative to HDAC1/2 in the MBD3-GFP pulldown is ~
0.4 (Supplementary Fig. 2c), suggesting that ZFP296 is a promi-
nent NuRD interactor in the soluble nuclear fraction. To verify
the detected interaction between NuRD and ZFP296, we gener-
ated an ESC line expressing ZFP296 with a GFP tag. Nuclear
extracts from this cell line were subjected to GFP afﬁnity pur-
iﬁcations followed by nLC-MS/MS (Fig. 2d) or immunoblotting
(Supplementary Fig. 2g, Supplementary Fig. 4). These experi-
ments conﬁrmed that ZFP296 interacts with the NuRD complex
in ESCs. Additionally, subunits of the SIN3A complex were
identiﬁed as statistically signiﬁcant ZFP296 interactors, indicating
that ZFP296 interacts with both the NuRD and SIN3A complexes
in ESCs (Fig. 2d; Supplementary Fig. 2h). Taken together, these
experiments revealed that certain NuRD-interacting proteins
display cell-type speciﬁc interaction dynamics.
ZFP296 co-localizes with NuRD and SIN3A in ESCs. To
investigate the putative function of ZFP296 as a NuRD- and
SIN3A-interacting protein, we performed ChIP-seq on the GFP-
tagged ZFP296 ESC line using a GFP antibody. 3102 GFP-
ZFP296 peaks were identiﬁed, and many of these overlap with
NuRD subunits MBD3 and CHD4, and SIN3A subunit SIN3A
(21%, 42%, and 18% of signiﬁcantly called peaks, respectively)
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Fig. 2 ZFP296 is an ESC-speciﬁc NuRD interactor. a, b Volcano plots from label-free GFP pulldowns on MBD3-GFP ESC (a) and MBD3-GFP NPC (b)
nuclear extracts. Statistically enriched proteins in the MBD3-GFP pulldowns are identiﬁed by a permutation-based FDR-corrected t-test. The label-free
quantiﬁcation (LFQ) intensity of the GFP pulldown relative to the control [fold change (FC), x-axis] is plotted against the −log10-transformed P-value of the
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c Volcano plot of the stoichiometry of MBD3-GFP interactors in ESCs and NPCs. The iBAQ value of each protein group is divided by the iBAQ value of the
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(Fig. 3a, b). Strikingly, the most enriched DNA sequence motif
under ZFP296 peaks is TTAGGG, which is the telomere repeat
motif (Fig. 3c). Additionally, the SOX2 and POU5F1/OCT4 DNA
binding motifs are also enriched at GFP-ZFP296 binding sites
(Fig. 3c). Furthermore, ZFP296 target genes (Supplementary
Data 1) are enriched for Gene Ontology (GO) terms related to
embryonic development (Fig. 3d). Lastly, we found that ZFP296
binding sites in the mouse ESC genome are marked with
H3K27ac, H3K4me1, H3K4me3, and p30019 (Fig. 3e). All these
ﬁndings are in agreement with the NuRD ChIP-seq results
(Fig. 1e and Supplementary Fig. 1c and d). ZFP296 binding sites
map to a mix of TSS (26%), intergenic (39%) and intronic regions
(30%), which is slightly enriched for TSS when compared to the
genomic distribution of a random subset of the same size and
average length (Fig. 3f). These results indicate that, similar to the
core NuRD subunits, most GFP-ZFP296 binding occurs at active
promoters and enhancers in ESCs.
KO of Zfp296 decreases NuRD binding genome-wide. Since
ZFP296 is both a putative DNA binding protein and has a stem
cell-speciﬁc expression pattern, we hypothesized that ZFP296
may be recruiting the NuRD complex to the ESC-speciﬁc loci
identiﬁed in Fig. 1. To address this hypothesis, we generated
several Zfp296 KO ESC clones using CRISPR/Cas9 and validated
them by mass spectrometry (Fig. 4a and Supplementary Fig. 3a,
b). Next, we performed ChIP-seq for MBD3 and CHD4 in two of
these Zfp296 KO cell lines while using a spike-in method to allow
for relative quantiﬁcation of the detected ChIP signal in wild-type
versus KO cells26. Deletion of ZFP296 from mouse ESCs resulted
in a decrease in NuRD binding particularly at ESC-speciﬁc NuRD
binding sites (Fig. 4b–d and Supplementary Fig. 3c, d), suggesting
that ZFP296 could contribute to the recruitment of NuRD to
these loci in a stem cell-speciﬁc manner. Indeed, loss of MBD3 at
ESC-enriched MBD3 binding sites in Zfp296 KO ESCs is more
pronounced when there is co-localization with ZFP296, sup-
porting such a recruiting function (Fig. 4e and Supplementary
Fig. 3e). Furthermore, a modest but reproducible average decrease
in NuRD binding could also be observed when looking at all
ZFP296 binding sites in ESCs (Fig. 4f and Supplementary Fig. 3f,
g). Importantly, these changes are unlikely to be caused by
changes in protein abundance, as NuRD complex subunits are
not signiﬁcantly altered in Zfp296 KO versus WT ESCs (Fig. 4a
and Supplementary Fig. 3a, b). Since we have shown that ZFP296,
apart from NuRD, also interacts and co-localizes with SIN3A, we
performed spike-in ChIP-seq for SIN3A in Zfp296 KO and WT
ESCs as well. However, SIN3A levels at ZFP296 sites were not
signiﬁcantly altered in both Zfp296 KO cell lines compared to WT
levels (Supplementary Fig. 3h). While the variance between the
two KO lines may be caused by a difference in ZFP296 depletion
(Fig. 4a and Supplementary Fig. 3a), these ﬁndings might also
suggest that the possible recruitment function of ZFP296 could be
more speciﬁc for NuRD. Lastly, we also used spike-in ChIP-seq to
study H3K27ac levels at ZFP296 sites in Zfp296 KO versus WT
ESCs, since H3K27ac is a known substrate for the NuRD com-
plex27, which showed that H3K27ac levels decreased in the one
but increased in the other Zfp296 KO cell line compared to WT
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ESCs (Supplementary Fig. 3h). Although also here the difference
in ZFP296 depletion may explain some of the variance between
the two lines, these ﬁndings may be in line with recent data
showing H3K27ac levels only change very transiently after NuRD
binding13. Together, these results indicate that ZFP296 may
contribute to ESC-speciﬁc NuRD binding.
Zfp296 KO cells exhibit delayed differentiation. To investigate
the global effects of the observed decrease in NuRD binding
genome-wide in Zfp296 KO versus wild-type ESCs, we performed
RNA sequencing and quantitative whole proteome analyses
(Fig. 5a, b). Despite the observed genome-wide changes in NuRD
binding, only mild effects on the global transcriptome and pro-
teome were observed. In total, 255 genes (out of 11,151 detected,
2.3%) were signiﬁcantly regulated at the transcript level and 134
proteins (out of 4780 detected, 2.8%) were differentially expressed
between Zfp296 KO and wild-type ESCs (Supplementary Data 3).
Of the genes whose transcript expression signiﬁcantly changed,
17% were bound by MBD3, and 23% were bound by ZFP296 in
wild-type cells, suggesting that these changes are both direct and
indirect effects of the KO. We observed a roughly equal pro-
portion of genes up- and downregulated in KO versus wild-type
cells. Although we only observed mild changes in gene expres-
sion, a few interesting genes were signiﬁcantly downregulated in
Zfp296 KO cells at the transcript and protein level. We veriﬁed
two of these, Dazl and Lefty2, using qRT-PCR analysis (Fig. 5c).
Based on the downregulation of these genes, which are important
for early lineage commitment, we hypothesized that Zfp296 KO
cells may display impaired differentiation capacity. To investigate
this, we differentiated Zfp296 KO and empty vector (EV) ESCs
into embryoid bodies. We followed a 4-day time course after LIF
withdrawal from the culture medium and observed a signiﬁcant
delay in the upregulation of several lineage identity genes across
all three germ layers (Fig. 5d). Pluripotency-associated genes were
efﬁciently downregulated in both cell lines. Thus, Zfp296 KO cells
are pluripotent but are impaired in their ability to switch on
lineage speciﬁcation genes.
Discussion
Here, we have identiﬁed the zinc ﬁnger protein ZFP296 as an
embryonic stem cell-speciﬁc interactor of the NuRD complex,
which additionally interacts with the SIN3A complex as well. This
shared interaction may be explained by the fact that NuRD and
SIN3A are both members of the HDAC1/2 complexes family and
as such contain shared subunits (apart from HDAC1/2 also
RBBP4/7). However, these subunits are also shared with for
example the CoREST complex, which we did not identify to be
co-puriﬁed with ZFP296 in ZFP296-GFP afﬁnity puriﬁcations. It
would therefore be interesting to perform direct interaction assays
such as cross-linking immunoprecipitation-MS28 to study which
proteins ZFP296 uses to associate with its interaction partners,
and on which factors these interactions are dependent. The
putative DNA binding ability of ZFP296 suggested a possible
function in recruitment of NuRD and/or SIN3A to speciﬁc target
genes, and indeed ChIP-sequencing experiments showed
decreased genome-wide binding of NuRD, but not SIN3A, upon
KO of Zfp296. The molecular mechanisms underlying this intri-
guing observation remain to be elucidated, but could be due to
the relative abundance of ZFP296 compared to core NuRD and
SIN3A subunits. Future studies focusing on SIN3A complex
composition and stoichiometry in ESCs could provide further
insights into this.
Motif enrichment analysis revealed a SOX2 and POU5F1/
OCT4 binding motif being enriched under NuRD peaks in ESCs,
consistent with a previously reported link between the NuRD
complex and the pluripotency network14,29. Although several
studies have reported direct protein-protein interactions between
NuRD and pluripotency factors such as POU5F1/OCT4 and
SOX215,16 we do not observe these or other pluripotency factors
as direct interactors of the NuRD complex in MBD3-GFP ESC
afﬁnity puriﬁcations. Furthermore, we failed to detect NuRD
subunits in POU5F1/OCT4 afﬁnity puriﬁcations. Thus, even
though the NuRD complex binds to genomic loci that are enri-
ched for POU5F1/OCT4 and SOX2 DNA binding motifs in
mouse ESCs, the molecular mechanisms responsible for NuRD
recruitment to these loci remain to be elucidated.
We and others5,23,24,29,30 have identiﬁed a large number of
putative DNA binding substoichiometric NuRD interactors. The
N-terminus of ZFP296 carries a motif, RRK, which is conserved
in several of these NuRD-interacting zinc ﬁnger proteins, such as
FOG1 and ZNF827. Interestingly, ZNF827 was recently shown to
recruit NuRD to telomeres31, suggesting that perhaps more RKK-
carrying zinc ﬁnger proteins regulate NuRD binding at repetitive
regions. Indeed, we identiﬁed the telomere repeat to be sig-
niﬁcantly enriched under ZFP296 binding sites in ESCs, although
we found no evidence that ZFP296 plays a role in recruiting
NuRD to repeats. However, a recent report linked ZFP296 to
regulation of H3K9me3 at major satellite repeats in early mouse
embryos32, indicating that the interplay between NuRD-
interacting zinc ﬁnger proteins and repeat regions remains an
area of active interest. Biochemical experiments using recombi-
nant proteins may shed more light on the DNA-binding prop-
erties of NuRD-interacting proteins such as ZFP296.
Recent work from the Schoeler lab revealed that
ZFP296 stimulates OSKM mediated iPSC formation25. In our
hands, Zfp296 KO ESCs remain pluripotent but are delayed in
their ability to differentiate upon LIF withdrawal from the culture
medium. This is in agreement with a recent study that showed
that ZFP296 is important for germ cell speciﬁcation33. Additional
investigations regarding NuRD and its role in regulating iPSC
formation and pluripotency have reported conﬂicting observa-
tions. Work from the Silva and Hendrich labs revealed that
NuRD is required for iPSC formation in a context-dependent
manner and that increased NuRD abundance can enhance
reprogramming efﬁciency34. In contrast, the Hanna lab showed
highly efﬁcient and deterministic iPSC formation in the absence
of MBD335, as well as other NuRD subunits36. Further work is
required to explore these contrasting results, but it will be
interesting to investigate whether ZFP296 also plays a role in
NuRD- or SIN3A-regulated iPSC reprogramming.
Methods
Cell culture and embryoid body differentiation. R1 mouse ESCs were obtained
from the ATCC and cultured on gelatine-coated plates in DMEM (Gibco) sup-
plemented with 15% HyClone foetal bovine serum (GE Healthcare Life Sciences),
GlutaMAX (Gibco), non-essential amino acids (Lonza), sodium pyruvate (Gibco),
penicillin–streptomycin (Gibco), β-mercaptoethanol, home-made LIF, 3 μM
PD0325901, and 1 μM CHIR99021. NPCs were differentiated and propagated
following the protocol from Conti et al.17. Brieﬂy, ESCs were differentiated into
NPCs using DMEM/F12 (Gibco), supplemented with Neurobasal medium (Gibco),
N2 and B27 supplements (Gibco), and β-mercaptoethanol. NPCs were maintained
in NSA (Euromed) supplemented with GlutaMAX (Gibco), N2 supplement
(Gibco), 10 ng/ml bFGF (100-18C, Perprotech), and 10 ng/ml EGF (236-EG, R&D
Systems). All cell lines have been tested for mycoplasma contamination.
BACs were tagged according to the protocol from Poser et al.21. GFP-tagged
BAC lines were prepped on NucleoBond BAC 100 columns (Macherey-Nagel) and
transfected into ESCs using Lipofectamine LTX Plus (Invitrogen), followed by
G418 selection for 10–12 days. Individual colonies were picked, expanded, and
screened for GFP expression.
GFP-ZFP296 ESCs were generated by transfection of a GFP-tagged ZFP296
construct into KH2 ESCs37. Full-length ZFP296 protein was cloned from mouse
complement DNA into the pcDNA3.1 vector (Invitrogen).
The CRISPR/Cas9 system was used to generate a Zfp296 KO cell line. A guide
RNA targeting the ﬁrst exon of Zfp296 (CCTCGCCGCGTAGATCCCGATAC or
CCATATCGGATGTGAAGCGTCAA) was cloned into pSpCas9(BB)-2A-Puro
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(PX459; Addgene 48139). The resulting plasmid was veriﬁed by sequencing and
transfected into R1 ESCs. After two days, the cells were subjected to puromycin
selection for 48 h, then monoclonal cell lines were generated and analyzed by
sequencing.
Wild-type and Zfp296 KO ESCs were differentiated into embryoid bodies by
plating 2 × 105 cells/mL of media onto non-adherent plates in the absence of LIF.
The medium was changed daily during the differentiation to embryoid bodies.
Chromatin preparation. Attached ESCs and NPCs were cross-linked with 1%
formaldehyde for 10 min at room temperature with gentle shaking. Cross-linking
was quenched with the addition of 1/10 volume 1.25 M glycine. Cells were washed
with PBS, then harvested by scraping in Buffer B (20 mM HEPES, 0.25% Triton X-
100, 10 mM EDTA, and 0.5 mM EGTA). Cells were pelleted by spinning at 600 × g
for 5 min at 4 °C. Cell pellet was resuspended in Buffer C (150 mM NaCl, 50 mM
HEPES, 1 mM EDTA, and 0.5 mM EGTA) and rotated for 10 min at 4 °C. Cells
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were pelleted by spinning at 600 × g for 5 min at 4 °C. The cell pellet was resus-
pended in 1× incubation buffer (0.15% SDS, 1% Triton X-100, 150 mM NaCl,
1 mM EDTA, 0.5 mM EGTA, and 20 mM HEPES) at 15 million cells/mL. Cells
were sheared in a Bioruptor Pico sonicator (Diagenode) at 4 °C using 5 or 7 cycles
of 30 s ON, 30 s OFF for ESCs and NPCs, respectively. Sonicated material was spun
at 18,000 × g for 10 min at 4 °C, then aliquoted and stored at −80 °C.
Chromatin immunoprecipitation. A total of 0.5–10 million cells were used as
input for library prep, and 5 million cells were used as input for ChIP-qPCR
experiments. Chromatin was incubated overnight together with 1 μg antibody at
4 °C in 1× incubation buffer (0.15% SDS, 1% Triton X-100, 150 mM NaCl, 1 mM
EDTA, 0.5 mM EGTA, and 20 mM HEPES) supplemented with protease inhibitors
and 0.1% BSA. For ChIPs with spike-in, 25 μg of sample chromatin and 50 or 20 ng
of spike-in chromatin (Active Motif) were used for histone modiﬁcation or tran-
scription factor ChIP, respectively. This chromatin mix was incubated overnight as
above, with 2 μg spike-in antibody (Active Motif) and 1 or 3 μg of the antibody of
interest for histone or transcription factor ChIP, respectively. A 50/50 mix of
Protein A and G Dynabeads (Invitrogen) was added the following day followed by
a 90-min incubation. The beads were washed 2× with Wash Buffer 1 (0.1% SDS,
0.1% sodium deoxycholate, 1% Triton, 150 mM NaCl, 1 mM EDTA, 0.5 mM
EGTA, and 20 mM HEPES), 1× with wash buffer 2 (wash buffer 1 with 500 mM
NaCl), 1× with wash buffer 3 (250 mM LiCl, 0.5% sodium deoxycholate, 0.5% NP-
40, 1 mM EDTA, 0.5 mM EGTA, and 20 mM HEPES), and 2× with wash buffer 4
(1 mM EDTA, 0.5 mM EGTA, and 20 mM HEPES). After washing, beads were
rotated for 20 min at room temperature in elution buffer (1% SDS, 0.1 M
NaHCO3). The supernatant was decrosslinked with 200 mM NaCl and 100 μg/mL
Proteinase K for 4 h at 65 °C. Decrosslinked DNA was puriﬁed using MinElute
PCR Puriﬁcation columns (Qiagen). DNA amount was quantitated using Qubit
ﬂuorometric quantitation (Thermo Fisher Scientiﬁc). qPCR analysis of ChIP DNA
was performed using iQ SYBR Green Supermix (Bio-Rad) on a CFX96 Real-Time
System C1000 Thermal Cycler (Bio-Rad). Primers used for qPCR analysis are listed
in Supplementary Table 1.
Illumina high-throughput sequencing and data analysis. ChIP-seq libraries were
prepared using the Kapa Hyper Prep Kit for Illumina sequencing (Kapa Biosys-
tems) according to the manufacturer’s protocol with the following modiﬁcations.
5 ng ChIP DNA was used as input, with NEXTﬂex adapters (Bioo Scientiﬁc) and 10
cycles of PCR ampliﬁcation. Post-ampliﬁcation clean-up was performed with
QIAquick MinElute columns (Qiagen) and size selection was done with an E-gel
(300 bp fragments) (Thermo Fisher Scientiﬁc). Size-selected samples were analyzed
for purity using a High Sensitivity DNA Chip on a Bioanalyzer 2100 system
(Agilent). Samples were sequenced on an Illumina HiSeq2000 or NextSeq500. The
43 or 75 bp tags were mapped to the reference mouse genome mm9 (NCBI build
37) or Drosophila genome dm3 (for spike-in) using the Burrows-Wheeler Align-
ment tool (BWA) allowing one mismatch38. Only uniquely mapped reads were
used for data analysis and visualization. Mapped reads were ﬁltered for quality and
duplicates were removed. Peak-calling was performed with the MACS 2.0 tool
against a reference input sample from the same cell line39. Heat maps and band
plots were performed using the Python package ﬂuff40. ChIP-seq datasets used for
generating heat maps and average proﬁles were normalized for the spike-in, or else
for RPKM. Motif analysis was performed using MEME ChIP41 and Gimme
Motifs42. GREAT43 was used for GO term analysis, and P-values were computed
using a hypergeometric distribution with FDR correction. R was used to generate
most of the graphs.
Nuclear extracts and nuclear pellet solubilization. Nuclear extracts were pre-
pared essentially according to Dignam et al.44. Brieﬂy, cells were harvested with
trypsin, washed twice with PBS, and centrifuged at 400 × g for 5 min at 4 °C. Cells
were swelled for 10 min at 4 °C in ﬁve volumes of Buffer A (10 mM HEPES/KOH,
pH 7.9, 1.5 mM MgCl2, 10 mM KCl), and then pelleted at 400 × g for 5 min at 4 °C.
Cells were resuspended in two volumes of Buffer A plus protease inhibitors and
0.15% NP-40 and transferred to a Dounce homogenizer. After 30–40 strokes with a
Type B pestle, the lysates were spun at 3200 × g for 15 min at 4 °C. The nuclear
pellet was washed once with PBS, and spun at 3200 × g for 5 min at 4 °C. The
nuclear pellet was resuspended in 2 volumes Buffer C (420 mM NaCl,
20 mM HEPES/KOH, pH 7.9, 20% v/v glycerol, 2 mMMgCl2, 0.2 mM EDTA) with
0.1% NP-40, protease inhibitors, and 0.5 mM dithiothreitol (DTT). The suspension
was incubated with rotation for 1 h at 4 °C, and then spun at 18,000 × g for 15 min
at 4 °C. The supernatant was aliquoted and stored at −80 °C until further use.
The nuclear pellets remaining after nuclear extraction were solubilized by
resuspension in four volumes of RIPA buffer (150 mM NaCl, 50 mM Tris pH 8.0,
1% NP-40, 5 mM MgCl2, 10% glycerol) plus benzonase (Millipore) at 1000 U/
100 ul nuclear pellet. Samples were incubated at 37 °C with shaking until
solubilized, then spun at 14000 × g for 5 min at 4 °C. The supernatant was aliquoted
and stored at −80 °C until further use.
Label-free pulldowns. Label-free GFP pulldowns were performed in triplicate as
previously described45 with the following modiﬁcations. For GFP pulldowns, 2 mg
of nuclear extract was incubated with 7.5 μl GFP-Trap beads (Chromotek) and
50 μg/mL ethidium bromide in Buffer C (300 mM NaCl, 20 mM HEPES/KOH,
pH 7.9, 20% v/v glycerol, 2 mM MgCl2, 0.2 mM EDTA) with 0.1% NP-40, protease
inhibitors, and 0.5 mM DTT in a total volume of 400 μl. After incubation, 6 washes
were performed: 2 with Buffer C and 0.5% NP-40, 2 with PBS and 0.5% NP-40, and
2 with PBS. Afﬁnity puriﬁed proteins were subject to on-bead trypsin digestion as
previously described22. In short, beads were resuspended in 50 μl elution buffer
(2 M urea, 50 mM Tris pH 7.5, 10 mM DTT) and incubated for 20 min in a
thermoshaker at 1400 rpm at room temperature. After addition of 50 mM
iodoacetamide (IAA), beads were incubated for 10 min at 1400 rpm at room
temperature in the dark. Proteins were then on-bead digested into tryptic peptides
by addition of 0.25 μg trypsin and subsequent incubation for 2 h at 1400 rpm at
room temperature. The supernatant was transferred to new tubes and further
digested overnight at room temperature with an additional 0.1 μg of trypsin.
Tryptic peptides were acidiﬁed and desalted using StageTips46 prior to mass
spectrometry analyses.
Label-free quantiﬁcation (LFQ) LC-MS/MS analysis. Tryptic peptides were
separated with an Easy-nLC 1000 (Thermo Scientiﬁc). Buffer A was 0.1% formic
acid and Buffer B was 80% acetonitrile and 0.1% formic acid. MBD3-GFP ESC and
NPC nuclear extract LFQ samples were separated using a 120-min gradient from
7% until 32% Buffer B followed by step-wise increases up to 95% Buffer B. Mass
spectra were recorded on a LTQ-Orbitrap Velos mass spectrometer or on a LTQ-
Orbitrap Q-Exactive mass spectrometer (Thermo Fisher Scientiﬁc), selecting the
10–15 most intense precursor ions of every full scan for fragmentation. The tryptic
peptides from GFP-ZFP296 ESC nuclear extracts, Zfp296 KO ESC nuclear extracts,
and ESC nuclear pellet pulldowns were measured by developing a gradient from
9–32% Buffer B for 114 min before washes at 50% then 95% Buffer B, for 140 min
of total data collection time. Mass spectra were recorded on an LTQ-Orbitrap
Fusion Tribrid mass spectrometer (Thermo Fisher Scientiﬁc). Scans were collected
in data-dependent top speed mode with dynamic exclusion set at 60 s.
Label-free and dimethyl-labeled proteomes. For label-free nuclear proteomes,
100 μg of nuclear extracts were digested using ﬁlter-aided sample preparation
(FASP)47 using a 30 kDa cut-off ﬁlter and trypsin digest in 50 mM ABC buffer. For
dimethyl-labelled whole proteomes, 100 μg of whole cell lysates were digested using
FASP using a 30 kDa cut-off ﬁlter and trypsin digest in TEAB buffer. For labeling,
each sample was differentially labeled after FASP by incorporation of stable iso-
topes on the peptide level using light and medium dimethyl labeling48. Differen-
tially dimethyl-labeled samples were mixed and fractionated by strong anion
exchange (SAX)49. We collected the ﬂow through (FT) and pH 11, pH 8, pH 5, and
pH 2 elutions. The peptides were subjected to Stage-Tip desalting46 prior to mass
spectrometry analysis. Peptides were applied to online nanoLC-MS/MS using a
214 min gradient of acetonitrile (7% to 30%) followed by washes at 60% then 95%
acetonitrile. Data were collected on a Fusion Tribrid mass spectrometer for
240 min of total data acquisition time.
Mass spectrometry data analysis. Thermo RAW ﬁles were analyzed with
MaxQuant version 1.5.1.0 or 1.6.0.1 using default settings and searching against the
UniProt mouse proteome, release 2015_12 or 2017_0650. Additional options for
Match between runs, LFQ, and iBAQ were selected where appropriate. Stoichio-
metry calculations and volcano plots were produced essentially as described22 using
Perseus51 version 1.4.0.8 and in-house R scripts. Statistical cut-offs were chosen
such that no proteins were present as outliers on the control, non-GFP side of the
volcano plot.
RNA-seq sample prep and analysis. RNA was isolated in duplicate from cells
using an RNeasy Mini Kit (Qiagen). Ribosomal RNA was depleted by treatment
with the Ribo-Zero rRNA Removal Kit (Illumina) and fragmented into approxi-
mately 200 bp fragments in fragmentation buffer (200 mM Tris-acetate, 500 mM
KCH3COO, 150 mM Mg(CH3COO)2, pH 8.2). Strand-speciﬁc libraries of cDNA
were prepared using SuperScript III Reverse Transcriptase (Invitrogen) and a Kapa
Hyper Prep Kit, as described above for ChIP-seq, but including an additional
incubation with USER enzyme (NEB) before library ampliﬁcation to digest the
second cDNA strand. Reads were mapped onto the reference mouse genome mm9
using hisat252. Count tables were generated using HTSeq53. Differential gene
expression was analysed with the DESeq2 R package.54
Quantitative reverse transcriptase PCR. RNA was isolated using the RNeasy
Mini Kit (Qiagen) and 1 μg of RNA was used for cDNA synthesis with the iScript
cDNA Synthesis Kit (Bio-Rad). qRT-PCR was performed using iQ SYBR Green
Supermix (Bio-Rad) on a CFX96 Real-Time System C1000 Thermal Cycler (Bio-
Rad). Primers used for qRT-PCR analysis are listed in Supplementary Table 2.
Gapdh and β-actin were used as the reference genes.
Co-immunoprecipitation and immunoblotting. For endogenous immunopreci-
pitation, 250 μg of nuclear extract in a total volume of 200 μl buffer C (300 mM
NaCl, 20 mM HEPES KOH pH 7.9, 20% (v/v) glycerol, 2 mM MgCl2, 0.2 mM
EDTA, 0.5% NP-40, 0.5 mM DTT, complete protease inhibitors) was incubated
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overnight with anti-MBD3 (IBL, JP10281, 2 μg per IP), followed by incubation with
20 μl of a 1:1 mixture of Protein A and G Dynabeads (Thermo Fisher) at 4 °C for
90 min. For GFP co-IPs, 7.5 μl of GFP-trap agarose beads (Chromotek) were
incubated with 250 μg of nuclear extracts in a total volume of 200 μl buffer C for
90 min at 4 °C. The beads were then washed three times with 1 mL buffer C and
ﬁnally boiled in Laemmli buffer.
Nuclear extracts or input samples (25 μg nuclear extract boiled in Laemmli
buffer) or immunoprecipitated proteins were fractionated by SDS-PAGE and
transferred to a nitrocellulose membrane using a transfer apparatus according to
the manufacturer’s protocol (Bio-Rad). After 1 h blocking with 5% milk in TBST
(10 mM Tris, pH 8.0, 150 mM NaCl, 0.5% Tween 20) at room temperature, the
membrane was incubated overnight at 4 °C using anti-MBD3 (IBL, JP10281, 1:1000
dilution), anti-SALL4 (abcam, ab29112, 1:5000 dilution), or anti-GFP (Roche,
11814460001, 1:2000 dilution). The membrane was washed 3 times with TBST
followed by incubation with a 1:3000 dilution of horseradish peroxidase-conjugated
anti-mouse or anti-rabbit antibodies (Dako; catalogue number p0260 and p0399,
respectively) in 5% milk in TBST at room temperature. Following secondary
antibody staining, the membrane was washed 3 times in TBST, followed by
development using the ECL Western Blotting Substrate (Promega) and imaging on
a ImageQuant LAS4000 (GE Healthcare). Uncropped western blots can be found in
Supplementary Fig. 4.
Data availability
The mass spectrometry proteomics data have been deposited to the ProteomeXchange
Consortium via the PRIDE partner repository55 with the dataset identiﬁer
PXD010512. High-throughput sequencing data have been deposited in the GEO
database repository with the dataset identiﬁer GSE117289. All ﬁgures have associated
raw data. All other relevant data are available from the corresponding author upon
reasonable request.
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